These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29194592)

  • 1. Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis.
    Kaplan B; Golderman S; Ganelin-Cohen E; Miniovitch A; Korf E; Ben-Zvi I; Livneh A; Flechter S
    Clin Exp Immunol; 2018 Apr; 192(1):7-17. PubMed ID: 29194592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis.
    Lotan I; Ganelin-Cohen E; Tartakovsky E; Khasminsky V; Hellmann MA; Steiner I; Ben-Zvi I; Livneh A; Golderman S; Kaplan B
    Mult Scler Relat Disord; 2020 Sep; 44():102339. PubMed ID: 32599469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
    Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
    J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Disease Monitoring in Pediatric Onset Multiple Sclerosis Using the Saliva Free Light Chain Test.
    Ganelin-Cohen E; Tartakovsky E; Klepfish E; Golderman S; Rozenberg A; Kaplan B
    Front Immunol; 2022; 13():821499. PubMed ID: 35450065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free light chain monomers in the diagnosis of multiple sclerosis.
    Kaplan B; Aizenbud BM; Golderman S; Yaskariev R; Sela BA
    J Neuroimmunol; 2010 Dec; 229(1-2):263-71. PubMed ID: 20870296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for new biomarkers of pediatric multiple sclerosis: application of immunoglobulin free light chain analysis.
    Ganelin-Cohen E; Golderman S; Yeskaraev R; Rozenberg A; Livneh A; Kaplan B
    Clin Chem Lab Med; 2018 Jun; 56(7):1081-1089. PubMed ID: 29408796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
    Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
    Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
    PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
    Goldis R; Kaplan B; Arad M; Dispenzieri A; Dasari S; Kukuy OL; Simon AJ; Dori A; Shavit-Stein E; Ziv T; Murray D; Kourelis T; Gertz MA; Dominissini D; Magen H; Muchtar E
    Clin Chem Lab Med; 2024 Feb; 62(3):464-471. PubMed ID: 37747270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
    Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
    Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.
    Desplat-Jégo S; Feuillet L; Pelletier J; Bernard D; Chérif AA; Boucraut J
    J Clin Immunol; 2005 Jul; 25(4):338-45. PubMed ID: 16133990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
    Hegen H; Walde J; Milosavljevic D; Aboulenein-Djamshidian F; Senel M; Tumani H; Deisenhammer F; Presslauer S
    Clin Chem Lab Med; 2019 Sep; 57(10):1574-1586. PubMed ID: 31112501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis.
    Nazarov V; Makshakov G; Kalinin I; Lapin S; Surkova E; Mikhailova L; Gilburd B; Skoromets A; Evdoshenko E
    Immunol Res; 2018 Dec; 66(6):761-767. PubMed ID: 30635824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of immunoglobulin free light chains at the debut of multiple sclerosis].
    Nazarov VD; Makshakov GS; Mazing AV; Surkova EA; Krasnov VS; Shumilina MV; Totolyan NA; Evdoshenko EP; Lapin SV; Emanuel VL; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):60-65. PubMed ID: 28617363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The association of intrathecal production of immunoglobulin free light chains and progression of multiple sclerosis].
    Makshakov GS; Nazarov VD; Totolyan NA; Lapin SV; Mazing AV; Emanuel VL; Krasnov VS; Shumilina MV; Skoromets AA; Evdoshenko EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10. Vyp. 2):4-10. PubMed ID: 29359727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.
    Gigante A; Pellicano C; Leodori G; Napodano C; Vantaggio L; Gulli F; Marino M; Visentini M; Rosato E; Basile U
    Clin Exp Immunol; 2021 Aug; 205(2):135-141. PubMed ID: 33934349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.